Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean A Fennell

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Nature Cancer|August 23, 2022
Accelerating innovations in systemic therapy for pleural mesotheliomaDean A Fennell, Aleksandra Bzura
The EPMA Journal|June 29, 2012
Unlocking Pandora's box: personalising cancer cell death in non-small cell lung cancerDean A Fennell, Charles Swanton
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Exploiting BH3 only protein function for effective cancer therapyDean A Fennell, Alex Chacko
The Lancet. Oncology|June 2, 2022
Abemaciclib for malignant pleural mesothelioma - Authors' replyDean A Fennell, Nada Nusrat
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2021
Chemotherapy With or Without Bevacizumab Should Be the Standard of Care for First-Line Unresectable Epithelioid MesotheliomaDean A Fennell, Sean Dulloo
The Lancet. Oncology|June 3, 2004
Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug developmentDean A Fennell, Robin M Rudd
Hospital Medicine (London, England : 1998)|August 28, 2004
Pulmonary toxicity and cancer treatmentDean A Fennell, Robin M Rudd
Oncotarget|January 25, 2020
Mesothelioma: Hippo pathway as a target, lessons from COMMANDDean A Fennell, Essa Y Baitei
Nature Reviews. Clinical Oncology|July 1, 2022
Immunotherapy approaches for malignant pleural mesotheliomaDean A Fennell, Sean Dulloo, James Harber
The New England Journal of Medicine|September 22, 2021
Perspectives on the Treatment of Malignant Pleural MesotheliomaSam M Janes, Doraid Alrifai, Dean A Fennell
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Nature Cancer|August 23, 2022
Accelerating innovations in systemic therapy for pleural mesotheliomaDean A Fennell, Aleksandra Bzura
The EPMA Journal|June 29, 2012
Unlocking Pandora's box: personalising cancer cell death in non-small cell lung cancerDean A Fennell, Charles Swanton
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Exploiting BH3 only protein function for effective cancer therapyDean A Fennell, Alex Chacko
The Lancet. Oncology|June 2, 2022
Abemaciclib for malignant pleural mesothelioma - Authors' replyDean A Fennell, Nada Nusrat
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2021
Chemotherapy With or Without Bevacizumab Should Be the Standard of Care for First-Line Unresectable Epithelioid MesotheliomaDean A Fennell, Sean Dulloo
The Lancet. Oncology|June 3, 2004
Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug developmentDean A Fennell, Robin M Rudd
Hospital Medicine (London, England : 1998)|August 28, 2004
Pulmonary toxicity and cancer treatmentDean A Fennell, Robin M Rudd
Oncotarget|January 25, 2020
Mesothelioma: Hippo pathway as a target, lessons from COMMANDDean A Fennell, Essa Y Baitei
Nature Reviews. Clinical Oncology|July 1, 2022
Immunotherapy approaches for malignant pleural mesotheliomaDean A Fennell, Sean Dulloo, James Harber
The New England Journal of Medicine|September 22, 2021
Perspectives on the Treatment of Malignant Pleural MesotheliomaSam M Janes, Doraid Alrifai, Dean A Fennell
Pageof 13